DIA 2023: Cal Collins Discusses SMART on FHIR and Supply Chains

A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models.

Tracy Lopez uncovers the fundamentals pertaining to third-party logistics providers.

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar gaps, reimbursement pressure from GLP-1s, and persistent access challenges.

Donald Prentiss discusses the value of these pharmacies, especially during shortages.

Brett Casper explores the marketplace complexities that manufacturers face regularly.

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug development landscape.